Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Legal & General Group (LGEN) by Royston Wild in The Motley Fool
- Watch Halma (HLMA) by James Beard in The Motley Fool
- Neutral Vistry Group (VTY) by Citi
- Buy Standard Chartered (STAN) by Simon Watkins in The Motley Fool
- Hold Vistry Group (VTY) by Jefferies
- Add Senior (SNR) by Stephen Wright in The Motley Fool
- Buy Senior (SNR) by Deutsche Bank
- Buy Vistry Group (VTY) by Deutsche Bank
- Hold London Stock Exchange Group (LSEG) by Deutsche Bank
- Buy Marks & Spencer Group (MKS) by Deutsche Bank
- Hold Vistry Group (VTY) by Berenberg
- Buy Bunzl (BNZL) by Christopher Ruane in The Motley Fool
- Equal Weight Spirax Group (SPX) by Barclays
- Underweight Vistry Group (VTY) by Barclays
- Sector Perform Severn Trent (SVT) by RBC Capital
- Sector Perform Pennon Group (PNN) by RBC Capital
- Outperform United Utilities Group (UU.) by RBC Capital
- Underweight InterContinental Hotels Group (IHG) by JP Morgan
- Overweight Imperial Brands (IMB) by JP Morgan
- Buy Sage Group (SGE) by Robert Stephens (Telegraph) in The Telegraph - Questor
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 17 open tips for Physiomics (PYC)
| Latest Bid : 0.65p | Latest Ask : 0.75p |
| High Today : 0.70p | Low Today : 0.68p |
| This Years High : 2.00p | This Years Low : 0.62p |
| Volume : 126,933 | MKT Cap : £1.52M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | -25.00% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -25.00% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 37.50% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 42.31% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 50.00% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.65p | Latest Ask : 0.75p |
| High Today : 0.70p | Low Today : 0.68p |
| This Years High : 2.00p | This Years Low : 0.62p |
| Volume : 126,933 | MKT Cap : £1.52M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | -25.00% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -25.00% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 37.50% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 42.31% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 50.00% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000